Metabolic alterations, such as oxidative stress, are hallmarks of HIV-1 infection. However, their influence on the development of viral latency, and thus on HIV-1 persistence during antiretroviral therapy (ART), have just begun to be explored. We analyzed omics profiles of in-vitro and in-vivo models of infection by HIV-1 and its simian homolog SIVmac. We found that cells survive retroviral replication by upregulating antioxidant pathways and intertwined iron import pathways. These changes are associated with remodeling of the redox sensitive promyelocytic leukemia protein nuclear bodies (PML NBs), an important constituent of nuclear architecture and a marker of HIV-1 latency. We found that PML is depleted in productively infected cells and restored by ART. Moreover, we identified intracellular iron as a key link between oxidative stress and PML depletion, thus supporting iron metabolism modulators as pharmacological tools to impair latency establishment.
Introduction
Since the discovery of HIV persistence during antiretroviral therapy (ART), the activation status of T-cells, and thus their metabolic activity, have been recognized as a primary determinant of HIV latency (Williams & Greene 2007) . Latency is the main obstacle to HIV-1 eradication and is characterized by persistence of integrated viral DNA that is transcriptionally silent, but replication competent. During therapy, integrated viral DNA is mainly found in memory CD4 + T-cells (Chomont et al. 2009; Hiener et al. 2017) where proviral reservoirs can become transcriptionally activated to trigger systemic infection upon ART discontinuation (Chun et al. 1998; Chun et al. 1999) . Latency is established early upon infection in vitro (Chavez et al. 2015) and in vivo (Chun et al. 1998 ) but the transcriptional mechanisms and metabolic pathways regulating the transition between productive and latent infection remain poorly explored.
Several concepts have been proposed to explain the development of HIV latency, and, among them, the reversal of activated cells to a resting state after infection is broadly accepted (Siliciano & Greene 2011) .
Among the different factors involved in this virus/host interplay, oxidative stress and the cellular antioxidant response have been linked to productive HIV-1 infection (Gorrini et al. 2013 ) and to reactivation from latency (Shytaj et al. 2013) . Oxidative stress is characterized by the generation and accumulation of byproducts of oxygen metabolism, reactive oxygen species (ROS), which can play a double faced toxic and/or regulatory role (Benhar et al. 2016) . To survive and regulate the accumulation of ROS, cells employ a plethora of antioxidant mechanisms. In particular, the Nuclear Factor, Erythroid 2 Like 2 (Nrf2) master gene is a transcriptional factor that regulates the expression of multiple antioxidant genes, including key redox modulators such as glutathione (GSH), nicotinamide adenine dinucleotide phosphate (NAPDH), the thioredoxin/thioredoxin reductase (Trx/TrxR1) axis, the quinone detoxifying agent NAD(P)H dehydrogenase (quinone 1) (NQO1) (Furuya et al. 2016; Zhang et al. 2009 ) and several molecules involved in cellular iron metabolism (Gorrini et al. 2013) . While therapeutic manipulation, based on either blocking antioxidant defenses to target latently infected cells or inhibiting oxidative stress to impair HIV-1 replication is currently under pre-clinical and clinical investigation (Benhar et al. 2016) ; NCT02961829), the study of the cellular antioxidant responses upon infection has led to conflicting results (Furuya et al. 2016; Zhang et al. 2009; Gill et al. 2014) .
Intracellular iron metabolism could represent a possible link between viral replication and redox signaling.
Inside cells, iron can be found in its ferric (Fe(III) or ferrous (Fe(II) forms, with the latter being reactive and capable of promoting oxidative stress through the Fenton reaction (Wang & Pantopoulos 2011) . The storage and export of iron are directly controlled by Nrf2, which regulates the ferritin H (FTH-1) iron storage molecule as well as the ferroportin (SLC40A1) iron exporter (Kerins & Ooi 2018; Muckenthaler et al. 2017) . Altered levels of the iron import protein, transferrin receptor 1 (TfR1, encoded by TFRC ) have been reported upon HIV-1 infection, and increased or decreased iron levels have been associated with enhanced or reduced viral replication, respectively, albeit only in cell lines (Savarino, Pescarmona, et al. 1999; Savarino, Calosso, et al. 1999; Drakesmith & Prentice 2008) . While the interplay between oxidative stress and iron metabolism has been well established, its role in the setting of HIV-1 infection and its impact on redox-sensitive cellular proteins regulating HIV-1 replication and latency has not been explored.
In this regard, another player potentially joining HIV-induced oxidative imbalance and latency maintenance is the promyelocytic leukemia protein (PML), which is the main building block of nuclear bodies (NB). The biogenesis of PML NBs, which associate with the silent viral genome in resting CD4 + T cells (Lusic et al. 2013) , depends on the oxidation process. Upon oxidative stress generation, NB shell formation is facilitated, and PML protein is subsequently sumoylated and subjected to degradation (reviewed in (Sahin, de Thé, et al. 2014) ). While we identified the proximity of silent proviral genomes to the PML NBs as a factor that contributes to maintenance of HIV-1 latency (Lusic et al. 2013) , the question of how the virus enters the latent phase and whether PML NBs play a role during this process remains open.
While several redox-effects on HIV expression/latency are known, a general picture on the sequence of redox-related events accompanying HIV latency are still lacking, and data have often been derived from tumor cell line models for latent HIV infection. Here we use omics data from a primary CD4 + T-cell model of HIV latency and ex-vivo transcriptomic profiles derived from rhesus macaques infected with the HIV homolog SIVmac (Palesch et al. 2018) to identify a pathway unraveling through HIV-1 replication, oxidative stress, iron import and PML NBs depletion/reformation. This pathway characterizes the transition between the productive and latent phase of HIV-1 infection and highlights potential new druggable targets for therapeutic applications.
Results

Antioxidant response is upregulated during productive in vitro and in vivo infection
To study the expression of antioxidant genes and proteins during the different stages of HIV-1 infection, we used a primary CD4 + T-cell model similar to those previously adopted by several groups (Bosque & Planelles 2009; Lusic et al. 2013; Martins et al. 2016 ) . In this model, CD4 + T-cells are activated through stimulation of CD3/CD28 receptors, infected with HIV-1 NL4-3 , and monitored over time until returning to a resting state ( Figure 1A ). This time course mimics distinct features of HIV-1 infection in vivo , i.e. a rapid initial growth of viral replication ( Figure 1B and 1C ) accompanied by cell death or establishment of a small pool of cells harboring integrated viral DNA that can be reactivated ( Figure 1D, 1E and 1F ).
Donor-matched mock infected controls are used to standardize gene and protein expression levels, while sampling of mRNA and proteins at different time points enables specific analysis of the various stages of infection. To elucidate the relationship between viral replication and oxidative stress, we conducted RNA-Seq ( Figure 2 ) and proteomic analyses ( Figure S1 ) of a macro-pathway including a large body of genes (n=401) related to oxidative stress. We observed enriched expression of antioxidant genes and proteins in infected compared to mock infected control cells. Interestingly, the peak of enrichment was observed at days 7-9 post-infection (henceforth, dpi) ( Figure S1 and 2A ), corresponding to the time interval during which HIV-1 replication reaches its zenith ( Figure 1B and 1C ) . Consistently, the antioxidant response decreases alongside establishment of latency. Indeed, when we focus our analyses on infected cells and normalize the data to the latent time point (14 dpi), we observe enriched expression of antioxidant genes during productive infection ( Figure 2B ).
To investigate the in-vivo relevance of our findings we further analyzed the expression of genes involved in oxidative stress response using a recently generated RNA-Seq dataset from an animal model closely recapitulating the main features of HIV infection (Evans & Silvestri 2013; Palesch et al. 2018 ) . This dataset is derived from peripheral blood mononuclear cells (PBMCs) of macaques chronically infected with the HIV homolog virus SIVmac in the presence or absence of ART. The use of this animal model provides an optimal in-vivo parallel of our in-vitro system, in that macaques can be standardized for viral inoculum, time/route of infection, and time points of analysis, with each animal acting as its own internal control before ART initiation (Evans & Silvestri 2013) . In agreement with our in-vitro data, a Gene Set Enrichment Analysis (GSEA) showed enriched expression of antioxidant genes before the administration of ART ( Figure 2C ).
In conclusion, both in-vitro and ex-vivo data show that transcriptional and protein expression of antioxidant genes is enriched during the productive stage of viral infection and that this effect is reversed, at least in part, upon transition to a resting/latent state.
HIV-1 replication drives nuclear translocation of Nrf2 and activation of its downstream antioxidant pathways
The transcriptomic and proteomic profiling of infected CD4 + T-cells points to a progressive enrichment of antioxidant defenses peaking with HIV-1 replication ( Figure S1 and Figure 2 ). This is further supported by a significant decrease in the reduced to oxidized glutathione (GSH/GSSG) ratio in infected versus mock infected control cells (mock: 53.0 ±8.5, infected: 38.9±9.2; mean ±SEM; P = 0.021, paired t -test, data not shown), which is indicative of oxidative stress (Giustarini et al. 2013) and is consistent with the previously reported generation of oxidative species upon infection (Pace & Leaf 1995) .
To characterize the antioxidant response upon HIV-1 infection we focused on the master transcription factor Nrf2 and its downstream antioxidant pathways. We first analyzed the subcellular localization of Nrf2, which is expected to relocalize from the cytosol to the nucleus upon activation (Ma 2013) . We found that productive HIV-1 infection is accompanied by Nrf2 nuclear translocation, as shown by biochemical fractionation ( Figure 3A ). Moreover, single molecule HIV-1 RNA FISH combined with immunofluorescence (IF) for Nrf2 showed that the nuclear content of Nrf2 was higher in cells actively producing the virus ( Figure 3B ). We next analyzed the expression of six representative Nrf2-target genes involved in the utilization, synthesis or detoxification of redox species such as GSH, NAPDH, thioredoxin (Trx), iron and quinones (Gorrini et al. 2013) . We observed a similar pattern of expression across all biological replicates ( Figure S2A ), with upregulation of all Nrf2 target genes during productive infection, both at the transcriptional ( Figure 3D ) and translational ( Figure 3E ) level. In all cases, a trend towards normalization to mock infected control levels was observed upon establishment of latency ( Figure 3D and 3E) . Moreover, a two-way ANOVA test highlighted the different time points (and thus stages) post-infection as the main source of variability ( P <0.0001), irrespective of the gene analyzed ( Figure   3D ). These results suggest a broad upregulation of the Nrf2-regulated pathways driven by the increase in HIV-1 replication.
Previous studies have linked the production of ROS to specific HIV-1 proteins, such as gp120 (Pietraforte et al. 1994 ) and reverse transcriptase (Isaguliants et al. 2013) , and to accessory proteins, in particular Nef (Vilhardt et al. 2002) and Tat (Gu et al. 2001; Zhang et al. 2009 ) .
To assess how single viral proteins modulate the redox status of the cell in the context of infection, we employed three different viral clones bearing mutations in the env (Pizzato et al. 2007) , nef (Trautz et al. 2016) or tat (Bejarano et al. 2019) genes . Compared to wild type HIV-1 NL4-3 , all mutant viruses exhibit the expected decrease in viral transcription ( Figure S2B ) and integration ( Figure S2C ), with the Δ tat mutant displaying the lowest fitness ( Figure S2B and S2C ). Of note, none of the mutant viruses triggers the upregulation of antioxidant genes ( Figure 3F ) when compared to their respective mock infected controls.
Furthermore, as viral replication increases (5-7 dpi), the expression of antioxidant genes in cells infected with the wild type virus is always higher than in cells infected with either of the mutant viruses ( Figure   3F ).
Overall, these data demonstrate that HIV-1 replication induces oxidative stress, followed by activation of Nrf2 and upregulation of its downstream pathways. Moreover, our results suggest that efficient viral replication, rather than single viral proteins, is required to activate the Nrf2 pathway.
Upregulation of Nrf2 targets and transition to latency are associated with increased iron import
Iron metabolism is a key target of Nrf2 signaling (Gorrini et al. 2013) . Our data highlighted heme oxygenase-1 (HMOX-1), the enzyme responsible for the catabolism of heme leading to ferrous iron (Fe(II)) release (Gozzelino et al. 2010) , as one of the antioxidant factors highly upregulated in the early infection stages ( Figure 3D and 3E ). To have a broader view of iron metabolism regulation during the different stages of infection, we analyzed the expression of several iron homeostasis genes in our omics data sets. RNA-Seq and proteomics data derived from our in-vitro model revealed enriched expression of mRNA and proteins regulating iron metabolism ( Figure 4A , left panel and Figure S3A left panel). The ex-vivo data derived from SIV-infected macaques further showed two sets of iron metabolism genes differentially enriched either before or during ART ( Figure 4A , right panel). As iron homeostasis can be regulated by mutually counteracting mechanisms (such as import and export) we narrowed our analyses to iron import regulation (Muckenthaler et al. 2017) . Both our in-vitro and ex-vivo data indicate enriched expression of iron import genes towards the transition to latency or after ART administration ( Figure 4B ).
In addition, the two iron transport proteins that could be detected in our proteomic analysis showed a similar trend ( Figure S3A , right). TfR1 was the iron import marker that could be readily detected in all our omics data sets. We thus verified its expression independently using flow cytometry (FACS) and IF ( Figure 4C and 4D and Figure S3B ). We observed an early decrease in TfR1 expression 3 dpi, most likely secondary to intracellular iron release through the action of HMOX-1 ( Figure 4C ). As viral replication progresses (7-9 dpi), an opposite pattern is observed ( Figure 4C and 4D and Figure S3B ),
showing enhanced iron import capacity via TfR1 internalization ( Figure 4D ) in infected cells during viral production and upon transition to latency. Absolute expression of TfR1 is decreased upon transition to a resting state (14dpi, Figure 4C and Figure S3B ), in line with the low expression of this marker in resting lymphocytes ( Figure S3C ). Yet, infected cells still display higher TfR1 expression compared to mock infected ( Figure 4C ), supporting the omics data and suggesting a persistent imbalance of iron metabolism in infected cells upon latency establishment. Consistently with the expression pattern of TfR1, FTH-1 and SLC40A1 expression was increased early upon infection suggesting enhanced iron storage and export, an effect that was reversed in the later stages ( Figure 4E ). Further supporting the notion that increased iron import sustains viral replication, the addition of non toxic levels ( Figure S3D ) of the iron donor FeCl 3 6H 2 O to the culture medium of infected cells was found to enhance gag p24 production.
Overall, these data show that intracellular iron levels are distinctively altered during the different stages of HIV-1 infection, with progressively increased iron import during the transition to latency.
HIV-1 replication induces degradation of the redox-sensitive latency marker PML
We then tested the impact of the above described metabolic imbalances on the host cells and the course of the infection. For this we examined the PML protein, which is redox-sensitive (Sahin, de Thé, et al. 2014; Niwa-Kawakita et al. 2017 ) and colocalizes with latent HIV-1 DNA (Lusic et al. 2013) . First, we analyzed the regulation of the PML pathway (including PML and its main interacting proteins) during the different stages of HIV-1 infection ( Figure 5A ) by comparing HIV-1 infected to mock infected cells.
Transcriptional enrichment of the PML pathway was observed in infected cells, peaking during productive infection ( Figure 5A ); a similar trend was observed in ex-vivo samples from SIVmac infected macaques (albeit without reaching statistical significance Figure 5B ). Conversely, protein levels displayed the highest enrichment in infected cells only at the latent time point ( Figure 5C ).
To explore the specific modulation of PML only, we analyzed its expression by qPCR and western blotting ( Figure 5D , left and right panels, respectively). We observed a progressive decrease in the amount of PML protein alongside the increase in viral replication (5-9 dpi), followed by a partial replenishment of PML upon transition to latency (14 dpi) ( Figure 5D , left panel). Of note, the level of PML mRNA displayed an opposite trend, suggesting a compensatory increase to counteract ongoing protein degradation ( Figure 5D , right panel). The trend displayed by PML was opposite to that observed for antioxidant defenses ( Figure 3C and 3D ). In line with this, uninfected CD4 + T-cells treated with the potent pro-oxidant H 2 O 2 showed rapid nuclear import of Nrf2 ( Figure S4A ) and decreased levels of PML ( Figure S4B ), albeit associated with high cellular mortality.
To estimate the impact of HIV-1 replication on PML depletion, we suppressed viral production using ART (5 dpi). The addition of ART abrogated p24 production in less than 48 hours (data not shown) and
restored PML protein to the mock infected control levels ( Figure 5E ).
To exclude potential biases due to bystander effects, which are typical of oxidative stress (Klammer et al. 2015) , we performed single cell analysis of cultures harboring HIV-1 nucleic acids. By combining HIV-1 DNA FISH with IF for PML NBs ( Figures 5F ), we confirmed degradation of PML during productive HIV-1 infection as well as its reformation in cells harboring latent HIV-1 ( Figure 5F ). Furthermore, single cell HIV-1 RNA FISH and IF staining for PML NBs proved that CD4 + T-cells productively infected with HIV-1 are characterized by lower numbers of PML NBs ( Figure 5G ). Identifying 3D objects, such as PML bodies, by projecting z-stacks in 2D can potentially bias the counting of such objects. Hence, we used an algorithm (described in materials and methods) that automatically generates 3D cell reconstructions and identifies HIV-1 RNA and PML NBs signals. The results confirmed significantly lower numbers of PML bodies in cells actively transcribing HIV-1 RNA ( Figure S4C and S4D ). Finally, as PML NBs have been previously described as possible restriction factors for HIV-1 replication (Dutrieux et al. 2015; Turelli et al. 2001; Kahle et al. 2015) we depleted PML with arsenic trioxide (As 2 O 3 ), ( Figure S5A , S5B and S5C ) and
infected the cells with either wild type HIV-1 NL4-3 or with the orange and green HIV-1 (OGH) dual color reporter virus that allows the discrimination between productive and latent infection based on expression of fluorescent markers (Vranckx et al. 2016; Calvanese et al. 2013 ) . The data showed increased viral production upon PML depletion ( Figure S5D and S5E ). Viral integration/latency, on the other hand, displayed variable trends ( Figure S5D and S5E ), suggesting that PML depletion through As 2 O 3 favors productive over latent HIV-1 infection ( Figure S5D ).
Overall these results show that PML is degraded by HIV-1 replication and suggest that the interplay between HIV-1 and PML might be both a cause and a consequence of viral production.
Iron mediates PML depletion upon HIV-1 infection
Both As 2 O 3 and iron (in particular in its ferrous state) can lead to increased ROS production, potentially influencing the stability of PML. We thus tested the effect of a non toxic (Ciciliano et al. 2015 ) ( Figure   S3D ) concentration of the iron donor FeCl 3 6H 2 O on PML NBs. We found that iron per se could induce PML and PML NBs depletion, recapitulating the effects of HIV-1 infection ( Figure 5D ). Of note, the effect or iron is lower compared to As 2 O 3 ( Figure 6A , 6B and 6C ). Treatment with As 2 O 3 has been previously associated with altered subcellular distribution of PML in cell lines, including increased cytoplasmic localization (Hands et al. 2014 ) . We used STimulated Emission Depletion (STED) microscopy to investigate the subcellular localization of PML NBs in primary CD4 + T-cells 48 hr after exposure to As 2 O 3 or FeCl 3 6H 2 O, respectively. However, we could not detect increased cytoplasmic PML NBs localization in any of the conditions examined ( Figure 6D ).
In addition to its action as pro-oxidant, it has been previously demonstrated that PML degradation by As 2 O 3 is at least in part mediated by arsenic replacing zinc through direct binding to the cysteine residues of the RING fingers located in the RING finger, B-box, and coiled-coil (RBBC) domain of PML (Zhang et al. 2010) . Similarities between the atomic radius of iron and zinc, and between the oxidation state of Fe(III) and As 2 O 3 , suggest a possible direct effect of iron on PML through replacement of zinc. We thus used a recently published high resolution crystal structure of PML RING domain tetramer to replace the zinc ion bound to PML with iron (Wang et al. 2018) . Our molecular modelling suggests that iron could in principle replace zinc in the RING finger ( Figure 6E ). However, the model showed that, unlike As 2 O 3 , the binding of either Fe(II) or Fe(III) does not alter the coordination of the cysteine residues nor the Fe-S binding length. Hence, these results suggest that iron alters PML stability mainly through its pro-oxidant effect.
To specifically investigate the role of iron as a mediator of PML depletion induced by HIV-1, we tested the effects of two iron chelators: deferoxamine (DFOA) and deferiprone (L1). Both compounds have been shown to possess antiviral activity (Georgiou et al. 2000) . To exclude potential bias and isolate the effect of iron chelation we selected non-toxic ( Figure S6A ) concentrations of DFOA and L1 that could reduce intracellular iron levels (as assessed by TfR1 upregulation, Figure S6B ), but did not impair HIV-1 replication ( Figure S6C ). Because long-term incubation with iron chelators decreased the viability of infected cells ( Figure S6D ) (Georgiou et al. 2002) , we analysed cells 5dpi, corresponding to a time point where PML is already depleted while cell viability is preserved. We found that incubation with either DFOA or L1 could revert PML depletion in infected cells, while leaving mock infected cells unaffected ( Figure 6F and 6G ).
Overall, these data prove that iron is sufficient and necessary to induce PML depletion in the context of HIV-1 infection, and suggest that the effect of iron on PML is exerted indirectly through enhancement of oxidative stress.
Discussion
Our study shows that dysregulation of cellular redox and iron metabolism is specifically driven by HIV-1 replication in CD4 + T-cells. Increasing oxidative stress and enhancing iron intake, leading to ROS generation, HIV-1 reshapes important components of the nuclear architecture, PML NBs, by causing depletion of PML protein and ultimately favoring further viral production. This self-sustaining mechanism is counteracted by a potent antioxidant response of the host, peaking concomitantly to maximal viral replication and preluding to latency establishment ( Figure 6H ).
We show that primary CD4 + T-cells surviving at peak of viral replication display enhanced iron-import capacity through TfR1. TfR1 upregulation in infected cells is likely associated with the utilization of iron for the activity of ribonucleotide reductase (Drakesmith & Prentice 2008) , which is essential for sustaining both cellular and viral replication. It is tempting to speculate that upregulation of TfR1 selects cells that can survive the increased iron consumption imposed by the infection, and therefore harbour latency. This hypothesis is in line with a previous study conducted in tumor cell line models, showing that downregulation of TfR1 is associated with death of HIV-infected cells (Savarino, Pescarmona, et al. 1999 ) . This is likely due to the fact that TfR1 downregulation, which in healthy cells limits iron overload, leads, in infected cells, to levels of iron intake that are unable to sustain both HIV-1 and cellular replication. In line with this model, the iron chelator L1 induced selective killing of the infected cell cultures. The increased iron requirement of infected cells is also supported by the persistence of increased iron import capacity upon development of latency in vitro and in vivo in macaques.
Iron binds TfR1 in its ferric (Fe(III) form, but, once imported in cells, is converted in endosomes to its reactive ferrous form Fe(II) (MacKenzie et al. 2008 ) . In the oxidized environment caused by HIV-1 infection, Fe(II) can in turn enhance ROS production through the Fenton reaction ( Figure 6H ). Evidence for an enhanced oxidative stress in our model is derived from the consumption of reduced glutathione (GSH), an intracellular antioxidant tripeptide which acts as a ROS scavenger (reviewed in (Benhar et al. 2016) ).
Noteworthy, the role of iron in regulating the stability of the redox-sensor PML protein is here proven.
Molecular modelling suggests that iron could replace zinc in the RING finger of PML, but that its PML-degrading effect is, unlike that of As 2 O 3 , probably indirect, and exerted through increased oxidative stress. Accordingly, we show that the potent ROS H 2 O 2 , in line with previous studies (Sahin, Ferhi, et al. 2014) , is able to deplete PML in CD4 + T-cells. The timing of maximal PML depletion during infection (7-9 dpi) further corroborates an indirect effect of iron, in that it overlaps with the upregulation of TfR1 in infected cells and consequently with the increased presence of the redox active Fe(II). Even though the binding of iron to the PML RING finger domain is not predicted to destabilize its structure with an arsenic-like mechanism, the spatial proximity resulting from this binding could increase the susceptibility to oxidation of the cysteines in the domain, as previously described for As 2 O 3 (Zhou et al. 2015) . Future studies will be required to test this hypothesis.
It was previously shown that PML depletion increases stability and nuclear translocation of the antioxidant master transcription factor Nrf2 (Guo et al. 2014; Niwa-Kawakita et al. 2017) . The antioxidant response that we observed in the present study is case in point, in that it was associated with broad activation of Nrf2 downstream targets. Moreover, the pattern of PML depletion mirrored that of the expression of Nrf2
targets, suggesting that degradation of PML might contribute to the generation of the potent antioxidant response induced by HIV infection.
Several studies have examined the independent role of single HIV-1 proteins in influencing the redox status of the cell (Pietraforte et al. 1994; Isaguliants et al. 2013; Vilhardt et al. 2002; Zhang et al. 2009; Gu et al. 2001 ) . While we could not ascribe the generation of antioxidant responses to any specific viral protein, our data show that these responses develop only in the presence of efficient and sustained replication of wild type HIV-1. In line with this, all the mutants tested in this study displayed antioxidant responses comparable to mock-infected cells. Previous studies have described both activation (Zhang et al. 2009 ) and inhibition of the Nrf2-regulated pathways upon HIV-1 infection (Gill et al. 2014) . Cell type differences might explain these discrepancies, in that inhibition of Nrf2 has been reported in myeloid cells, in particular in the central nervous system (Gill et al. 2014) . Antioxidant responses were decreased upon latency establishment in our model, but this did not lead to their full normalization, as compared to mock-infected cells. In line with this, a previous study indicated upregulation of antioxidant defenses in latently infected cell lines as compared to their uninfected counterparts (Bhaskar et al. 2015) . By combining omics data sets and single cell analyses, the present study contributes to a general picture of the interplay between redox and iron metabolism in the setting of HIV-1 infection. It presents, though, some limitations such as circumscribing the analyses to bulk CD4 + T-cells or PBMCs to allow for longer post-infection follow-up. Different T-cells subsets are, however, characterized by variable baseline antioxidant defenses (Chirullo et al. 2013 ) and could thus contribute to a different degree to the effects that we observed. Of note, a recent study has elegantly characterized the metabolic activity of T-cell subsets and shown the correspondence with their different predisposition to HIV-1 infection (Valle-Casuso et al. 2018) . Another potential limitation of our study is the combined analysis of all different isoforms of PML, which can independently influence its function and localization (Condemine et al. 2006) . Further studies will be required to investigate if specific isoforms of PML might be differentially influenced by
HIV-1 infection.
Overall, the present work proves that HIV-1 can alter the nuclear structure of the host and favor its own replication by increasing oxidative stress and intracellular iron import, while the cellular response to these effects preludes to latency development. Moreover, these data open the possibility of combining drugs to increase oxidative stress and iron content to induce PML degradation and target the HIV-1 reservoir.
Materials and Methods
Primary CD4 + T-cell isolation and culture
Whole blood of healthy donors was provided by Heidelberg University Hospital Blood Bank following approval by the local ethics committee . CD4 + T-cells were isolated using the RosetteSep™ Human CD4 + T Cell Enrichment Cocktail (STEMCELL Technologies Inc., Vancouver, British Columbia, Canada)
following manufacturer's instruction. After isolation cells were activated by adding the Dynabeads®
Human T-Activator CD3/CD28 using a bead/cell ratio of 1:2. Cells were cultured in RPMI 1640
supplemented with 20% fetal bovine serum (FBS), penicillin/streptomycin, and 10 ng/mL IL-2 and kept at a concentration between 1-2 *10 6 cells/mL in an incubator at 37°C in a 5% CO 2 atmosphere. Three days after activation cells were infected and/or treated with drugs as described below.
In-vitro infection with HIV-1
For in-vitro infection, 5-20*10 6 activated CD4 + T-cells were used. Cells were pelleted and infected using either wt HIV-1 NL4-3 (2ng p24/10 6 cells) the nef mutated virus described in (Trautz et al. 2016 ) (10ng p24/10 6 cells; HIV-1 NL4-3 Δ nef ), the dual color OGH HIV-1 virus (Calvanese et al. 2013 ) (1μg p24/10 6 cells), the tat mutated virus described in (Bejarano et al. 2019 ) (1μg p24/10 6 cells; HIV-1 NL4-3 Δ tat ) or env mutated virus pseudotyped with vesicular stomatitis virus glycoprotein (Pizzato et al. 2007 ) (1μg p24/10 6 cells; HIV-1 NL4-3 Δ env ). For infection with the wt HIV-1 NL4-3 or HIV-1 NL4-3 Δ nef virus, cells were left 2-4 hr in an incubator at 37°C and 5% CO 2 . For infection with the OGH virus, HIV-1 NL4-3 Δ tat and HIV-1 NL4-3 Δ env , cells were spinoculated at 2300rpm for 1.5 hr at 37°C. Following infection cells were washed and resuspended at 1*10 6 cells/mL in RPMI 1640 supplemented with 20% FBS and 10 ng/mL IL-2.
Drug treatments
For testing pharmacologically-induced PML depletion or iron overload/chelation CD4 + T-cells at day 3 post-activation were left untreated, or treated with 1) arsenic trioxide ( 
RNA-Seq analyses
RNA sequencing was performed on an Illumina Next Seq platform and CASAVA was used to perform base calling. The quality of the 2x75 bp reads was assessed with FastQC ( https://www.bioinformatics.babraham.ac.uk/projects/fastqc/ ). STAR (Dobin et al. 2013 ) version 2.5 was used to align raw reads to build version hg38 of the human genome and to calculate counts for GENCODE (release 25) basic annotated genes. Normalization and differential analysis were carried out using the DESeq2 R package (Love et al. 2014) . Genes were considered differentially expressed with an adjusted p-value lower than 0.05.
Gene sets representing the activity of pathways were derived from the Molecular signature database (Liberzon et al. 2011) . The statistical over-representation of gene sets among differentially expressed genes and proteins was assessed with a one-tailed Fisher exact test. R (version 3.3.1) was used for statistical analyses.
Proteomic analysis
Sample preparation was performed using the Single-Pot Solid-Phase-enhanced Sample Preparation approach SP3, as described elsewhere (Hughes et al. 2019 For library generation the mass spectrometer was operated in data-dependent acquisition mode. The MS1 survey scan was acquired from 350-1300 m/z at a resolution of 70,000. The top 10 most abundant peptides were isolated within a 2 Th window and subjected to HCD fragmentation at a normalized collision energy of 27%. The AGC target was set to 5e5 charges, allowing a maximum injection time of 55 ms. Product ions were detected in the Orbitrap at a resolution of 17,500. Precursors were dynamically excluded for 20 s. A data-independent acquisition method was employed for protein quantification. The mass spectrometer was operated in data-independent acquisition (DIA) mode. The MS1 scan was acquired from 400-1220 m/z at a resolution of 140,000. MSMS scans were acquired for 10 DIA windows at a resolution of 35,000. The AGC target was set to 3e6 charges. The default charge state for the MS2 was set to 4. Stepped normalized collision energy was set to A, B, C = 23.5%, 26%, 28.5%. The MSMS spectra were acquired in profile mode. Data analysis: The raw data of the pooled library samples were processed with Maxquant (version 1.5.3.8) using default parameters. Briefly, MS2 spectra were searched against the Uniprot human database, including a list of common contaminants. False discovery rates on protein and PSM level were estimated by the target-decoy approach to 1% (Protein FDR) and 1% (PSM FDR) respectively. The minimal peptide length was set to 7 amino acids and carbamidomethylation at cysteine residues was considered as a fixed modification. Oxidation (M) and Acetyl (Protein N-term) were included as variable modifications. The match-between runs option was disabled. For DIA quantification raw data were processed with Spectronaut Pulsar X (version 11) using default parameters. Briefly, MS2 spectra were searched against the previously generated library. The maximum of major group Top N was set to 6, the decoy method to inverse and the data filtering was set to Qvalue.
Measurement of reduced (GSH) and oxidized (GSSG) cell content
Measurement of GSH/GSSG content was performed using the GSH/GSSG-Glo™ Assay (Promega;
Madison, WI, USA) according to manufacturer´s instruction. Briefly 5* 10 5 CD4 + T-cells were lysed and incubated with a specific probe emitting luciferin in glutathione-dependent reaction. For detection of 
Flow Cytometry
For surface staining, 500*10 5 cells were pelleted and fixed in PBS + 4% paraformaldehyde (PFA). Cells were then washed twice with cold FACS buffer (PBS + 2% FCS) and incubated in the dark at 4 o C with an anti-TfR1 (CD71) antibody (clone OKT9; Thermo Fisher Scientific, Waltham, MA, USA). Cells were then washed with PBS and resuspended in FACS buffer. For intracellular staining, the two initial washes were performed with PBS containing 0.5% Triton x-100 and cells were stained for 30 min with an α-p24 (gag) antibody (Coulter Clone KC57-RD1; Beckman Coulter). Data were acquired with a BD FACSVerse flow cytometer and analyzed using the FlowJo package (FlowJo LLC, Ashland, Oregon, USA v7.6.5).
RNA and DNA extraction and quantification
Total RNA and genomic DNA were extracted using, respectively, the InviTrap® Spin Universal RNA Mini Kit (Stratec Biomedical, Germany) and the DNeasy Blood & Tissue Kits (Qiagen, Germany) according to manufacturers' instruction. Nucleic acids were quantified using a P-class P 300 NanoPhotometer (Implen GmbH, Munich, Germany).
Reverse transcription and quantitative polymerase chain reaction (qPCR)
Total RNA was retrotranscribed to cDNA using the SuperScript III Reverse Transcriptase kit (Thermo Polymerase activation/DNA denaturation 98°C 3 min, followed by 45 cycles of Denaturation at 98°C for 10 s; Annealing/Extension at 60°C for 40 s. Final extension was performed at 65°C for 30 s, followed by slow cool down to 4° C -0.5° C/s.
Integrated HIV DNA measurement
The integrated HIV-1 DNA content was assessed using a nested Alu-LTR PCR assay as previously described (Tan et al. 2006) . Briefly, in the first round of PCR, Alu-LTR fragments were amplified starting from 250ng of genomic DNA. For the second round, products of the first PCR were diluted 1:50 in H 2 O and LTR-LTR fragments amplified in a qPCR. A housekeeping gene, i.e. lamin B2, B13 region, was run in parallel in the second round of PCR using 10ng of genomic DNA and used to normalize the data as described in the statistical analyses section.
MTT assay
Viability upon treatment with the drugs employed was measured through the CellTiter 96®
Non-Radioactive Cell Proliferation Assay (MTT) assay (Promega; Madison, WI, USA) similarly to (Shytaj et al. 2015) . Briefly, 300*10 5 cells were resuspended in 100 μL RPMI + 10% FCS and transferred to a 96-well plate. To each well was added the MTT solution (15 μL) and, after 2-4 hr, the reaction was 
Stimulated emission depletion (STED) microscopy
STED imaging was performed with a λ=775 nm STED system (Abberior Instruments GmbH, Göttingen, Germany), containing an easy 3D optics module (Abberior Instruments) and the =640 nm excitation laser line using a 100x Olympus UPlanSApo (NA 1.4) oil immersion objective. Images were acquired using the 590 and 640 nm excitation laser lines.
Additional confocal images of eGFP signals excited at 488 nm were acquired. Deconvolution of STED images was performed in Imspector software (Abberior Instruments) via the linear deconvolution tool.
Images were further processed in Fiji-Imagej (Schindelin et al. 2012 ) by using the Gaussian-Blur Filter and setting the sigma radius to 1 to further increase signal/noise ratio. Different analyzed excitation channels from the same sample were also merged into one image by using this software.
Confocal microscopy
Data were acquired using a Leica TCS SP8 confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany) with a 63x objective immersed in oil. A distance (z-step) of 500 nm was used to acquire three dimensional stacks with zoom set at 1x or 3x.
Image analysis was performed with Fiji-Imagej (Schindelin et al. 2012 ) using the following macros to perform automatic segmentation and counting of the number of cells and PML bodies:
Segmentation:
//run("Brightness/Contrast..."); setMinAndMax(0, 150); run("Gaussian Blur...", "sigma=2 stack"); //run("Threshold..."); setAutoThreshold("RenyiEntropy dark"); setThreshold(40, 255); //setThreshold(40, 255); setOption("BlackBackground", true); run("Convert to Mask", "method=RenyiEntropy background=Dark black"); roiManager("Show None"); roiManager("Show All"); count:
run("Duplicate...", "duplicate"); run("3D Objects Counter", "threshold=1 slice=16 min.=1 max.=356796 objects statistics summary");
3D FISH PML analysis algorithm
We developed an algorithm, implemented in MATLAB, in order to automatically analyse 3D RNA FISH and PML proteins in fluorescence cell image z-stacks. The algorithm is derived from Gregoretti et al.
(manuscript submitted) with some adaptations. It performs the 2D segmentation of cell nuclei and the detection of FISH and PML spots for each slice of the stack followed by the 3D reconstruction and identification of nuclei and spots. It then counts and measures the 3D FISH and PML spots and calculate the total intensity value of FISH spots. We recognized as infected those cells with HIV-1 RNA FISH signals satisfying these constraints: 1) at least one signal with size greater than 200 voxels; 2) total intensity of FISH signals greater than 15000. The algorithm can be sketched as follows:
for each slice n of the stack Output image nuclei n highlights foreground objects (nucleus regions). The function detect_spot has four major steps. It first filters the input image I FISH,n ( I PML.n ) applying the Laplacian of Gaussian (LoG) operator ( fspecial MATLAB function) of size 9 and standard deviation 7. This enhances the signal in the areas where objects are present. Then the function applies the h-dome transformation (Vincent 1993 ) that extracts bright structures by cutting off the intensity of height h from the top, around local intensity maxima. We used h=0.5 with a neighborhood size of 15x15. We decided to not use a global operator after having observed that a FISH spot (PML spot) in one part of the image could be lighter or darker than the background in another part. This is due to the facts that spots have inhomogeneous intensity distribution over the image and that the image may have an uneven background. In the third step, the function performs a thresholding on h-domes image that excludesGold pixels whose intensity values are below a threshold. The FISH and PML threshold values are defined as 1.96 and 1 standard deviations above the mean of domes intensity values, respectively. We therefore assumed that spot areas have significant intensity disparity with respect to other bright areas present in cell nucleus. Lastly, the function applies a thresholding operation based on the surface areas of the spots, in order to discard too small objects which are probably just noise. It filters out spots smaller than a surface area of 8. detect_spot
produces an accurate set of FISH and PML spots.
fish_vol , pml_vol and nuclei_vol are 3D arrays that contain the positions of the detected FISH and PML spots and nuclei from all slices.
3D reconstructions of nuclei are obtained through the connected components algorithm ( bwconncomp MATLAB function, using a connectivity of 6). 3D nuclei are then labeled by applying the labelmatrix MATLAB function so they can easily separated each from the others.
The algorithm computes the volume of each 3D reconstruction, discarding, as noise, objects whose volume is less than 10% of mean volumes.
The algorithm uses the bwareaopen function in order to discard too small detected spot objects which are probably just noise. 3D reconstructions of spots are obtained through the connected components algorithm ( bwconncomp MATLAB function, using a connectivity of 6). Then a threshold operation is performed on the 3D spots to obtain the more significant ones: it keeps in all the PML spots whose volume is above 0.15 micron cubes and all the FISH spots whose volume is above 100 voxels.
Biochemical fractionation, SDS-PAGE, and Western Blot
Cytoplasmic and nuclear cell fractions were prepared from 10 to 20x10 6 cells. Briefly, cell pellets were resuspended in cytoplasmic buffer: 10mM Tris pH 7.9; 3mM CaCl 2 , 2mM MgCl 2 , 0.1 mM EDTA, 0.34 M sucrose, 1mM DTT supplemented with protease inhibitors (Roche). After swelling in cytoplasmic buffer on ice for 5 min, Triton X-100 was added to the final concentration of 0.1%. Cytoplasm was extracted after 10 min incubation and 10 min centrifugation at 3000 rpm at 4C. Nuclei were washed in the same buffer without the detergent, and lysed in nuclei lysis buffer: 20 mM Hepes pH 7.9; 2.5 mM MgCl2; 0.5mM EDTA; 150mM KCl; 10% glycerol; 0.5% NP 40 plus protease inhibitors (add fresh) on ice for 10 min.
Nucleic acids were removed with 250 U of Benzonase (Roche) for 1 hr at 4 o C. Nuclear soluble fraction was extracted by addition of high salt buffer to achieve 250 mM KCl for 1 hr at 4 o C rotating, followed by 45 min centrifugation at maximum speed at 4 o C. Alternatively, cytoplasmatic and nuclear cell fractions were isolated using the REAP method, according to the published protocol (Suzuki et al. 2010) .
For SDS-Page experiments 1-5* 10 6 cells were harvested and homogenized in lysis buffer (20 mM Tris buffer and 110 mM ß-mercaptoethanol) for 15 min at 65 o C. After extensive washing with 0,1 % PBS-Tween, membrane was blocked and reincubated with desired antibodies.
Statistical analysis
qPCR and Alu PCR values were normalized using the 2(-ΔΔ C(T)) method (Livak & Schmittgen 2001) .
Comparisons between two groups were performed by unpaired t -test. Three or more groups were compared by either one way or two way ANOVA followed by the appropriate post-test for multiple comparisons. 
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